 has ordered the suspension of the manufacture of Tasty Tom Enriched Tomato Mix.){kind=link}
The Food and Drugs Authority (FDA) has ordered the suspension of the manufacture of Tasty Tom Enriched Tomato Mix.
According to the Food and Drugs Authority (FDA), there have been some safety breaches at the production facility of Nutrifoods Ghana Limited.
In a statement issued on Sunday, August 3, by the FDA, all canned Tasty Tom Enriched Tomato Mix products and batches of the product in 380g and 1.05kg pouches have been recalled.
The FDA revealed numerous consumer complaints, and an investigation led to their decision.
FDA inspection also found poor maintenance of key manufacturing equipment and a lack of adequate monitoring systems.
The FDA statement read, “Accra: August 3, 2025 – The Food and Drugs Authority (FDA) has suspended the manufacture of Tasty Tom Enriched Tomato Mix with immediate effect. A market recall of all canned Tasty Tom Enriched Tomato Mix products, and specific batches of the product in pouches (the 380g and 1.05kg pouches) was earlier directed by the FDA”.
The statement added, “The suspension follows consumer complaints and FDA’s investigation of Nutrifoods Ghana Limited’s manufacturing plant, which established infractions on standards and quality. Maintenance of critical manufacturing equipment was poor, and monitoring systems were inadequate to protect public health and safety.
The lapses at the manufacturing plant affected the integrity of the canned products by compromising the sealing mechanisms, leading to contamination and bloating of the products in pouches Mold was found on some of them, raising serious health and safety concerns, hence the suspension and product recall”.
The FDA further revealed, Nutrifoods were earlier barred from manufacturing the product in January 2025.
“In line with the FDA’s commitment to transparency and accountability, internal investigations have commenced to ascertain if there were regulatory lapses, particularly because Nutrifoods had earlier in January 2025 been barred from manufacturing the product. Any dereliction of duty identified will be swiftly dealt with in order to strengthen the FDA’s regulatory oversight”.
The FDA statement further urged consumers, retailers and wholesalers to take note of this directive
“The Authority advises consumers, retailers and wholesalers to take note of this directive and act accordingly. We will continue to exercise rigorous oversight in accordance with our mandate to protect public health and safety”, the statement added.
See the statement below:
